Boryung Pharm (003850) — Cash Flow Reinvestment Rate
Boryung Pharm (003850) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting ₩6.89 Billion (capex ₩4.92 Billion plus investments ₩-1.97 Billion) from operating cash flow of ₩48.95 Billion. Check 003850 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Boryung Pharm Cash Flow Reinvestment Rate (2009–2024)
Historical reinvestment intensity for Boryung Pharm across 12 annual periods. Explore 003850 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Boryung Pharm (2009–2024)
Year-by-year capital reinvestment analysis for Boryung Pharm. For live market cap and broader valuation context, see Boryung Pharm market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.26x | ₩21.02 Billion | ₩80.56 Billion | ₩20.05 Billion | ▼ -79.0% |
| 2023 | 1.24x | ₩52.51 Billion | ₩42.22 Billion | ₩23.35 Billion | ▼ -49.9% |
| 2022 | 2.48x | ₩69.06 Billion | ₩27.81 Billion | ₩20.28 Billion | ▲ +329.3% |
| 2021 | 0.58x | ₩34.80 Billion | ₩60.17 Billion | ₩16.13 Billion | ▼ -70.4% |
| 2020 | 1.95x | ₩87.43 Billion | ₩44.74 Billion | ₩18.27 Billion | ▲ +21.7% |
| 2019 | 1.61x | ₩75.50 Billion | ₩47.00 Billion | ₩67.02 Billion | ▲ +14.0% |
| 2018 | 1.41x | ₩54.83 Billion | ₩38.91 Billion | ₩54.83 Billion | ▼ -77.7% |
| 2016 | 6.33x | ₩59.22 Billion | ₩9.36 Billion | ₩26.83 Billion | ▲ +1065.3% |
| 2012 | 0.54x | ₩9.98 Billion | ₩18.38 Billion | ₩9.98 Billion | ▼ -64.8% |
| 2011 | 1.54x | ₩14.17 Billion | ₩9.19 Billion | ₩14.16 Billion | ▲ +23.6% |
| 2010 | 1.25x | ₩30.08 Billion | ₩24.12 Billion | ₩29.77 Billion | ▼ -61.5% |
| 2009 | 3.24x | ₩11.64 Billion | ₩3.59 Billion | ₩11.28 Billion | — |